321 related articles for article (PubMed ID: 25568205)
21. The human immunodeficiency virus (HIV) Rev-binding protein (HRB) is a co-factor for HIV-1 Nef-mediated CD4 downregulation.
Landi A; Timermans CG; Naessens E; Vanderstraeten H; Stove V; Verhasselt B
J Gen Virol; 2016 Mar; 97(3):778-785. PubMed ID: 26701340
[TBL] [Abstract][Full Text] [Related]
22. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.
Jafari M; Guatelli J; Lewinski MK
J Virol; 2014 May; 88(9):5062-78. PubMed ID: 24574397
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
[TBL] [Abstract][Full Text] [Related]
24. Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice.
Sato K; Misawa N; Fukuhara M; Iwami S; An DS; Ito M; Koyanagi Y
J Virol; 2012 May; 86(9):5000-13. PubMed ID: 22357275
[TBL] [Abstract][Full Text] [Related]
25. [Establishment of a high-throughput screening assay for interaction inhibitor between BST-2 and Vpu].
Pang XJ; Hu SQ; Zhang Y; Cen S; Jin Q; Guo F
Bing Du Xue Bao; 2012 Nov; 28(6):633-8. PubMed ID: 23367562
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
[TBL] [Abstract][Full Text] [Related]
27. Functional conservation and coherence of HIV-1 subtype A Vpu alleles.
Romani B; Kavyanifard A; Allahbakhshi E
Sci Rep; 2017 Dec; 7(1):87. PubMed ID: 28273896
[TBL] [Abstract][Full Text] [Related]
28. Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism.
Lukhele S; Cohen ÉA
Retrovirology; 2017 Mar; 14(1):18. PubMed ID: 28288652
[TBL] [Abstract][Full Text] [Related]
29. The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis.
Xu Z; Lodge R; Power C; Cohen EA; Hobman TC
mBio; 2020 Mar; 11(2):. PubMed ID: 32127461
[TBL] [Abstract][Full Text] [Related]
30. β-TrCP dependency of HIV-1 Vpu-induced downregulation of CD4 and BST-2/tetherin.
Blanchet FP; Mitchell JP; Piguet V
Curr HIV Res; 2012 Jun; 10(4):307-14. PubMed ID: 22524179
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses.
Prévost J; Pickering S; Mumby MJ; Medjahed H; Gendron-Lepage G; Delgado GG; Dirk BS; Dikeakos JD; Stürzel CM; Sauter D; Kirchhoff F; Bibollet-Ruche F; Hahn BH; Dubé M; Kaufmann DE; Neil SJD; Finzi A; Richard J
mBio; 2019 Jun; 10(3):. PubMed ID: 31213558
[TBL] [Abstract][Full Text] [Related]
32. Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.
Vanwalscappel B; Rato S; Perez-Olmeda M; Díez Fuertes F; Casartelli N; Alcami J; Mammano F
Virology; 2017 Jan; 500():247-258. PubMed ID: 27855354
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
Fritz JV; Tibroni N; Keppler OT; Fackler OT
Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
[TBL] [Abstract][Full Text] [Related]
34. High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2.
Zhang Q; Liu Z; Mi Z; Li X; Jia P; Zhou J; Yin X; You X; Yu L; Guo F; Ma J; Liang C; Cen S
Antiviral Res; 2011 Sep; 91(3):321-9. PubMed ID: 21777622
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.
Dubé M; Paquay C; Roy BB; Bego MG; Mercier J; Cohen EA
Traffic; 2011 Dec; 12(12):1714-29. PubMed ID: 21902775
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Vpu Mediates HLA-C Downregulation.
Apps R; Del Prete GQ; Chatterjee P; Lara A; Brumme ZL; Brockman MA; Neil S; Pickering S; Schneider DK; Piechocka-Trocha A; Walker BD; Thomas R; Shaw GM; Hahn BH; Keele BF; Lifson JD; Carrington M
Cell Host Microbe; 2016 May; 19(5):686-95. PubMed ID: 27173934
[TBL] [Abstract][Full Text] [Related]
37. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Neil SJ; Zang T; Bieniasz PD
Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
[TBL] [Abstract][Full Text] [Related]
38. Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.
Kuhl BD; Sloan RD; Donahue DA; Liang C; Wainberg MA
Virology; 2011 Sep; 417(2):353-61. PubMed ID: 21757214
[TBL] [Abstract][Full Text] [Related]
39. Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317.
Bolduan S; Votteler J; Lodermeyer V; Greiner T; Koppensteiner H; Schindler M; Thiel G; Schubert U
Virology; 2011 Jul; 416(1-2):75-85. PubMed ID: 21601230
[TBL] [Abstract][Full Text] [Related]
40. Tetherin restricts direct cell-to-cell infection of HIV-1.
Kuhl BD; Sloan RD; Donahue DA; Bar-Magen T; Liang C; Wainberg MA
Retrovirology; 2010 Dec; 7():115. PubMed ID: 21184674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
